Combined adenocarcinoid and mucinous cystadenoma of the appendix: a case report by Velusamy, A et al.
BioMed  Central
Page 1 of 3
(page number not for citation purposes)
Journal of Medical Case Reports
Open Access Case report
Combined adenocarcinoid and mucinous cystadenoma of the 
appendix: a case report
A Velusamy*1, S Saw2, J Gossage1, STR Bailey1 and J Schofield2
Address: 1Department of Surgery, Maidstone Hospital, Maidstone ME16 9QQ, UK and 2Department of Pathology, Preston Hall Hospital, 
Aylesford, Kent ME20 7NJ, UK
Email: A Velusamy* - avsamy@gmail.com; S Saw - soniasaw@nhs.net; J Gossage - jgossage@doctors.org.uk; STR Bailey - simonbailey@nhs.net; 
J Schofield - john.schofield@nhs.net
* Corresponding author    
Abstract
Introduction: Adenocarcinoid of the appendix is a rare malignant tumour with features of both
adenocarcinoma and carcinoid, showing both epithelial and endocrine differentiation. Mucinous
cystadenoma is the commonest of the benign neoplasms of the appendix, with an incidence of 0.6%
in appendicectomy specimens. We report a rare combination of these tumours and discuss the
latest treatment options. To the best of our knowledge, only six cases have been reported in the
literature to date.
Case presentation: A 71-year-old Caucasian man presented to our department with a right iliac
fossa mass associated with pain. Laparoscopy revealed an adenocarcinoid of the appendix in
combination with mucinous cystadenoma. He underwent a radical right hemicolectomy with clear
margins and lymph nodes.
Conclusion: Adenocarcinoids account for 2% of primary appendiceal malignancies. Most tumours
are less than 2 cm in diameter and 20% of them metastasize to the ovaries. The mean age for
presentation is 59 years and the 5-year survival rate ranges from 60% to 84%. Right hemicolectomy
is generally advised if any of the following features are present: tumours greater than 2 cm,
involvement of resection margins, greater than 2 mitoses/10 high-power fields on histology,
extension of tumour beyond serosa. Chemotherapy mostly with 5-Fluorouracil and Leucovorin is
advised for remnant disease after surgery. Cytoreductive surgery with intraperitoneal
chemotherapy can offer improved survival for advanced peritoneal dissemination.
Introduction
Mucinous cystadenoma is the commonest of the benign
neoplasms of the appendix, with an incidence of 0.6% in
appendicectomy specimens [1]. Adenocarcinoid is a rare
but well recognised tumour of the appendix which exhib-
its features of both carcinoid and adenocarcinoma. We
report a patient with combined adenocarcinoid and muci-
nous cystadenoma of the appendix. To the best of our
knowledge, only six cases have been reported in the liter-
ature to date [2,3].
Case presentation
Case report
A 71-year-old man presented to the surgical department
with a 2-week history of colicky right iliac fossa pain and
a 1-week history of diarrhoea. He did not have rectal
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bleeding or weight loss. On examination, he was found to
have a right iliac fossa mass. Serum carcinoembryonic
antigen (CEA) was <2 μg/L and the computed tomogra-
phy (CT) scan revealed an appendiceal mass (Figure 1)
without any surrounding lymph node enlargement.
Laparoscopy showed an appendiceal mass with mucinous
discharge and a laparoscopic appendicectomy was per-
formed. Histology revealed both an adenocarcinoid
involving the resected margin and a mucinous cystade-
noma of the tip. The patient subsequently underwent a
laparoscopic radical right hemicolectomy. The right colon
and all of the 15 lymph nodes resected were clear of
tumour.
Pathology
Macroscopically, the normal anatomy of the appendix
was distorted with dilatation and mucocele formation.
Histology revealed a mucinous cystadenoma involving
the tip of the appendix. Proximally, the appendix was
infiltrated by adenocarcinoid composed of islands of epi-
thelial cells with abundant intracellular mucin and eosi-
nophilic granules (Figure 2). The tumour measured at
least 12 mm in maximum diameter with extension to the
serosal surface and into the mesoappendix. The tumour
was present at the surgical resection margin. Mucin stains
were positive and immunohistochemical stains showed
strong positivity for chromogranin, CD56 and CK20,
whilst CK7 was negative. The resected right colon showed
no residual tumour and the lymph nodes were not
involved.
Conclusion
Adenocarcinoid is recognised as a tumour which has fea-
tures of both adenocarcinoma and carcinoid, first
described by Gagne et al. in 1969 [4]. It is widely known
by different names such as goblet cell carcinoid [5], crypt
cell carcinoid, and amphicrine cell carcinoma. There is
still debate about the origin of this tumour and several
hypotheses exist, hence the various nomenclature. Aden-
ocarcinoma arises from primordial endodermal elements
while carcinoid arises from neural crest cells. Some
authors suggest that goblet cell carcinoids arise from a
pluripotent cell with divergent neuroendocrine and muci-
nous differentiation [6].
Mucinous cystadenoma is rare but is the commonest of
the benign appendiceal tumours. It can present as appen-
dicitis, mucocele or if the tumour ruptures, as pseu-
domyxoma peritonei. Treatment is usually
appendicectomy with care taken not to spill the mucin
intraperitoneally.
Adenocarcinoids account for 2% of primary appendiceal
malignancies. Most tumours are less than 2 cm in diame-
ter and 20% of them metastasize to the ovaries [7]. The
mean age at presentation is 59 years and the 5-year sur-
vival rate ranges from 60% to 84% [8]. The tumour usu-
ally spares the mucosa, infiltrates muscularis propria and
peri-appendiceal fat and can stain positively for mucin,
Computed tomography scan showing appendix mucocele Figure 1
Computed tomography scan showing appendix 
mucocele.
(A) Mucinous cystadenoma and goblet cell carcinoid with  hematoxylin and eosin (×200) Figure 2
(A) Mucinous cystadenoma and goblet cell carcinoid 
with hematoxylin and eosin (×200). (B) Goblet cell 
mucin positive with alcian blue/diastase/periodic acid Schiff 
stain (×200). (C) Chromogranin immunohistochemistry posi-
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CEA, cytokeratin, lysozyme, chromogranin A, serotonin
and synaptophysin. Goblet cell carcinoids have increased
expression of NAP1L1, MAGE-D2, and MTA-1 genes com-
pared with benign carcinoids. Ki 67 is a tumour marker
which is expressed in higher levels in metastatic adenocar-
cinoids compared to localized ones. This can be useful in
predicting tumour behaviour and subsequent surgical
management [9]. Recent studies suggest that goblet cell
carcinoids have biological and immunohistochemical
profiles more similar to adenocarcinoma than to classical
carcinoids which may explain their more aggressive
behaviour and therefore substantiate more extensive treat-
ment [10,11].
There is ongoing surgical controversy as to whether
appendicectomy or right hemicolectomy is necessary for
appendiceal carcinoid tumours. For classical carcinoid
tumours, most centres consider tumour size to be the
main discretionary factor. Those <2 cm are usually treated
with appendicectomy alone. For adenocarcinoids, right
hemicolectomy is generally advised if any of the following
features are present: tumours greater than 2 cm, involve-
ment of resected margins, greater than 2 mitoses/10 high-
power fields (hpf), extension of tumour beyond serosa,
lymphovascular invasion or lymph node metastases
[12,13]. Some authors recommend right hemicolectomy
for adenocarcinoids of any size due to their propensity to
metastasize [7], while others use similar determinative
histological criteria as those for classical carcinoids to plan
treatment [13]. A meta-analysis of retrospective chart
reviews by Varisco et al. evaluated the efficacy of appendi-
cectomy versus hemicolectomy for localized adenocarci-
noids. Their analysis suggests appendicectomy alone has a
role in the treatment of localized tumours. However, in
the presence of unfavourable features including moderate
to severe atypia, involvement of caecum, and more than 2
mitoses per hpf, they recommend an interval hemicolec-
tomy [14].
Chemotherapy mostly with 5-Fluorouracil and Leucov-
orin is advised for remnant disease after surgery. Cytore-
ductive surgery with intraperitoneal chemotherapy can
offer improved survival for advanced peritoneal dissemi-
nation [8]. In female patients regardless of age, bilateral
salpingo-oopherectomy is advocated, as there is a signifi-
cant risk of ovarian involvement. Irrespective of the type
of surgical intervention, all patients warrant lifelong
colonoscopic surveillance.
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